Coriolis Pharma and U-Medico Announce a Strategic Alliance

MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire / -- Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs located in Germany, and U-Medico, an innovative formulation development and biophysical characterisations service provider located in Japan, today announce a strategic alliance that includes an equity investment by Coriolis Pharma into U-Medico.
More info >>